Debt-to-equity of Bionik Laboratories Corp. from 30 Jun 2012 to 31 Mar 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bionik Laboratories Corp. quarterly Debt-to-equity in % history and change rate from 30 Jun 2012 to 31 Mar 2023.
  • Bionik Laboratories Corp. Debt-to-equity for the quarter ending 31 Mar 2023 was -34842%, a 4744% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Bionik Laboratories Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2023 -34842% -35592% -4744% 31 Mar 2023
Q4 2022 258% -519% -67% 31 Dec 2022
Q3 2022 2957% +2667% +921% 30 Sep 2022
Q2 2022 1021% 30 Jun 2022
Q1 2022 750% 31 Mar 2022
Q4 2021 777% 31 Dec 2021
Q3 2021 290% 30 Sep 2021
Q1 2017 23% -829% -97% 31 Mar 2017
Q4 2016 24% -711% -97% 31 Dec 2016
Q3 2016 36% -763% -95% 30 Sep 2016
Q2 2016 78% -285% -79% 30 Jun 2016
Q1 2016 852% 31 Mar 2016
Q4 2015 735% 31 Dec 2015
Q3 2015 799% 30 Sep 2015
Q2 2015 363% 30 Jun 2015
Q2 2012 -15%* 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.